KR20030079231A - Topical cosmetic products which have anti-acne efficacy for the patients with acne and their manufacturing methods. - Google Patents
Topical cosmetic products which have anti-acne efficacy for the patients with acne and their manufacturing methods. Download PDFInfo
- Publication number
- KR20030079231A KR20030079231A KR1020020018102A KR20020018102A KR20030079231A KR 20030079231 A KR20030079231 A KR 20030079231A KR 1020020018102 A KR1020020018102 A KR 1020020018102A KR 20020018102 A KR20020018102 A KR 20020018102A KR 20030079231 A KR20030079231 A KR 20030079231A
- Authority
- KR
- South Korea
- Prior art keywords
- acne
- cosmetic composition
- composition
- skin
- ethanol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
Abstract
Description
본 발명은 피부 병변중 피지 및 미생물에 의한 피부 여드름에 대하여 치유 효과를 가지는 화장료 조성물 및 그의 제조방법에 관한 것으로서, 본 조성물의 항여드름 효과는 피부 부작용 없이 1차적으로는 여드름 원인 균주의 성장 저해 메카니즘에 기인하며, 2차적으로는 피부 각질 제거 및 피지선의 막힘을 제거함으로써 모공 내의 염증을 예방하여 궁극적으로는 여드름 피부에 개선효과를 부여해 준다.The present invention relates to a cosmetic composition having a healing effect on skin acne caused by sebum and microorganisms in skin lesions, and a method of manufacturing the same, wherein the anti-acne effect of the composition is primarily a growth inhibition mechanism of acne-causing strains without skin side effects. Secondly, by exfoliating the skin and removing sebaceous glands, it prevents inflammation in the pores and ultimately gives an acne skin improvement effect.
일반적으로 여드름은 얼굴뿐만 아니라 여러 부위의 피부(등, 가슴)에 발생되며 이러한 발생의 원인으로는 신체 호르몬, 피지의 과잉분비, 각질층에 의한 모낭의 막힘 및 그에 따른 유해 미생물의 번식 등이 있다. 이러한 여러 가지 요인들의 복합작용으로 발생하는 여드름에 대해서 여러 가지 치료법이 행해지고 있는 실정이다. 대표적인 치료법으로는 에리스로마이신, 클린다마이신과 같은 항생물질을 피부에 도포하는 것, benzoyl peroxide, 비타민 A 유도체 등을 피부에 도포하는 것, 경구용 항생제를 복용하는 것, 레이져를 이용하는 것 등의 여러 가지 방법들이 행해지고 있다. 그러나 이러한 치료법들은 약물 및 물리적인 방법에 의한 치료법으로서 장기간 사용하는 데에는 피부 부작용 등의 문제가 발생될 수 있다. 특히 항생물질에 의한 치료법은 항생제에 대한 내성의 문제점이 야기될 수 있다. 여드름의 치료는 일순간에 가능한 것이 아니라 꾸준하고도 지속적인 관리가 필요하나 상기의 방법들은 여드름 환자에게 있어서 많은 부담을 준다고 할 수 있다. 그에 반해 본 화장료 조성물은 2단계 시스템으로 여드름 발생 균주와 피부 각질 제거에 의한 모공 막힘 제거에 효능을 가지는 물질들을 조합하여 이를 부형제에 배합시켜 사용함으로써 피부에 부담을 덜어줌과 동시에 항여드름 치료 효과를 극대화시켜 지속적으로 여드름을 관리하여 여드름의 재발을 방지할 수 있는 커다란 장점이 있다고 할 수 있다.In general, acne develops not only on the face but also on the skin (back, chest) of various parts. The causes of the occurrence include body hormones, excessive secretion of sebum, clogging of hair follicles by the stratum corneum, and the reproduction of harmful microorganisms. Various treatments are being performed on acne caused by a combination of these various factors. Typical treatments include applying antibiotics such as erythromycin and clindamycin to the skin, applying benzoyl peroxide and vitamin A derivatives to the skin, taking oral antibiotics, and using lasers. Are done. However, these therapies may cause problems such as skin side effects with long-term use as drugs and physical methods of treatment. In particular, treatment with antibiotics can cause problems with resistance to antibiotics. Acne treatment is not possible at a moment, but requires a steady and continuous management, but the above methods can be said to put a lot of pressure on acne patients. On the other hand, the cosmetic composition is a two-step system that combines an acne-producing strain and a substance that is effective in removing pore blockage by skin exfoliation, and uses it in an excipient to reduce the burden on the skin and to treat anti-acne. It can be said that there is a big advantage to prevent acne recurrence by continually managing acne.
이에 본 발명은 상기의 사용상의 문제점, 피부 부작용 등의 문제점을 해결함과 동시에 항여드름 효과를 극대화시키기 위하여 여드름 균주에 대해 항균효과를 가지는 것으로 보고된 성분들과 피부 각질 제거에 효과적인 성분을 조합하여 이를 여드름 피부에 적용한 결과, 알려진 다른 치료법들에 비해 매우 효과적임을 알게되어 본 발명을 완성하였다. 따라서 본 발명은 의약품이 아닌 화장료 조성물로서 연령대의 제한이 없이 범용적으로 장기간 사용 가능하며 여드름으로 고민하는 사람들의 피부를 지속적으로 관리하여 여드름의 치료 및 재발을 방지해 주는 화장료 조성물을 제공하는데 그 목적이 있다.Therefore, the present invention combines the components reported to have an antimicrobial effect against acne strains and the components effective to remove the skin exfoliation in order to solve the problems of use, skin side effects and at the same time to maximize the anti-acne effect. As a result of applying it to acne skin, it was found that it is very effective compared to other known therapies, thus completing the present invention. Therefore, the present invention is a cosmetic composition that is not a pharmaceutical composition can be used universally for a long time without limitation of age and to provide a cosmetic composition that prevents the treatment and recurrence of acne by continuously managing the skin of people suffering from acne There is this.
도 1은Propionibacterium acnes에 대하여 본 발명에 따라 제조된 화장료 조성물과 다른 조성물과의 항균능 비교 사진이다. E는 erythromycin, C는 clindamycin, B는 본 발명에 의한 화장료 조성물, I는 isopropyl alcohol과 에탄올의 혼합물을 의미한다.1 is a photograph comparing the antimicrobial activity of the cosmetic composition prepared according to the present invention with respect to other compositions for Propionibacterium acnes . E is erythromycin, C is clindamycin, B is a cosmetic composition according to the present invention, I is a mixture of isopropyl alcohol and ethanol.
본 발명은 여드름 피부에 대해 효과적인 성분을 함유하는 화장료 조성물에 있어서 에탄올 및 이소피로필알코올의 부형제 내에 스핑고리피드, 살리실산,Candida bombicola균주의 glucose/methyl rapeseedate 발효에 의한 대사산물, AHA 성분인 젖산이 용해 분산되어 있는 여드름 개선용 화장료 조성물을 그 특징으로 한다.The present invention relates to a cosmetic composition containing an effective ingredient for acne skin, metabolites by glucose / methyl rapeseedate fermentation of sphingolipid, salicylic acid and Candida bombicola strains in excipients of ethanol and isopyrophyll alcohol, and lactic acid as an AHA component. It is characterized by a cosmetic composition for improving acne that is dissolved and dispersed.
이러한 상기 조성물은 에탄올 10 - 50 중량%, 스핑고리피드 0.01 -0.5 중량%, 살리실산 0.01 - 1.0 중량%,Candida bombicola발효 대사산물 0.01 - 5 중량%, 젖산 0.1 - 10 중량%, 이소프로필알코올 20 - 60 중량%, 정제수 13 5 - 29.87중량%가 함유되어 있다. 또한 본 발명의 바람직한 제조방법으로는,This composition comprises 10-50% by weight of ethanol, 0.01-0.5 % by weight of sphingolipid, 0.01-1.0 % by weight of salicylic acid, 0.01-5% by weight of Candida bombicola metabolite, 0.1-10% by weight of lactic acid, 20-% of isopropyl alcohol. 60 weight percent and 13 5-29.87 weight percent purified water. Moreover, as a preferable manufacturing method of this invention,
1) 스핑고리피드를 에탄올에 용해시키는 단계,1) dissolving sphingolipid in ethanol,
2) 별도의 용해조에 살리실산을 이소프로필알코올에 용해시키는 단계,2) dissolving salicylic acid in isopropyl alcohol in a separate dissolution tank,
3) 상기 준비된 1), 2)에Candida bombicola발효 대사산물과 젖산, 정제수를 첨가하여 분산시킨 다음 여과시키는 단계를 포함하는 것을 특징으로 한다. 이러한 제조방법에서 상기 1), 2)의 각 단계에 향, 방부제 및 또다른 유효성분 중에서 선택된 1종 이상을 첨가하여 혼합시키는 단계를 추가로 포함할 수 있다.3) Candida bombicola fermentation metabolite, lactic acid, and purified water were added and dispersed in 1) and 2) prepared above, followed by filtration. In this manufacturing method, the steps of 1) and 2) may further include mixing by adding one or more selected from fragrances, preservatives and another active ingredient.
이하, 본 발명을 실시예에 의거하여 더욱 상세하게 설명하겠는바, 본 발명이 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited by Examples.
실시예 1Example 1
다음 표 1에 나타낸 조성에 따라 제조하였으며, 그 제조방법은 다음과 같다.It was prepared according to the composition shown in Table 1, the production method is as follows.
A상의 성분들을 완전 용해시키고 별도의 용해조에서 B상의 성분들을 완전 용해시킨 다음 A상을 B상에 첨가하여 혼합 균일화시켰다. 여기에 C상과 D상의 성분들을 순차적으로 첨가하여 혼합 균일화 시킨 다음 여과시켜 본 조성물을 제조하였다.The components of phase A were completely dissolved and the components of phase B were completely dissolved in a separate dissolution bath, followed by addition of phase A to phase B to homogenize mixing. The components of the C and D phases were added sequentially, homogenized and filtered to prepare the composition.
실시예 2Example 2
상기의 실시예 1과 동일한 방법으로 제조하였으며, 그 조성은 다음 표 1에 나타내었다.Prepared in the same manner as in Example 1, the composition is shown in Table 1 below.
비교예 1Comparative Example 1
실시예의 경우와 비교하기 위해 부형제, 항생제가 함유되는 조성물을 각각 제조하였으며, 그 조성비는 표 2에 나타내었다. 제조방법은 먼저 A상의 성분들을 완전 용해시킨 다음 B, C상의 성분을 각각 순차적으로 참가하여 혼합 균일화시킨 다음 여과시켜 조성물을 제조하였다.In order to compare with the case of the examples, an excipient and a composition containing antibiotics were prepared, respectively, and the composition ratios are shown in Table 2. In the manufacturing method, the components of phase A were completely dissolved, and then components of phases B and C were sequentially added to each other, homogenized, mixed, and filtered to prepare a composition.
비교예 2, 3Comparative Examples 2 and 3
상기의 비교예 1과 동일한 방법으로 제조하였으며, 그 조성은 다음 표 2에 나타내었다.It was prepared in the same manner as in Comparative Example 1, the composition is shown in Table 2 below.
시험예Test Example
1) 항균력 시험1) Antibacterial test
실시예 1, 2 및 비교예 1 ∼ 3의 조성으로 제조된 각각의 화장료 조성물을 여드름 원인 균주인Propionibacterium acnes에 대하여 항균력을 시험하여 그 결과를 다음 표 3에 나타내었다. 조사법으로는 평원반 평판(disc plate)법을 사용하였다. 이 방법은 한천 평판 배지에P. acnes균주를 도말한 후 실시예 및 비교예 조성물을 처리한 평원(paper disc)을 올려놓고 배양하여, 생성된 생장 저해 부위(inhibition zone)의 크기를 조사함으로써 조성물에 대한 감수성을 조사하였다.Each cosmetic composition prepared in the compositions of Examples 1, 2 and Comparative Examples 1 to 3 were tested for antibacterial activity against Propionibacterium acnes , a strain of acne-causing strains, and the results are shown in Table 3 below. Disc plate method was used as an irradiation method. This method is characterized by spreading the P. acnes strain on agar plate medium and incubating with a paper disc treated with the Examples and Comparative Examples composition, and then examining the size of the generated inhibition zone (inhibition zone). The susceptibility to was investigated.
2) 임상시험 : 유효성 및 부작용2) Clinical trial: efficacy and side effects
여드름 환자 30명을 대상으로 여드름이 발생한 병변 국소 부위에 실시예 2와 비교예 2를 blind test 방식으로 적용하여 그 비교 결과를 표 4에 나타내었다.Example 4 and Comparative Example 2 were applied to a blind spot where acne occurred in 30 acne patients, and the comparison results are shown in Table 4 below.
상기 표 4를 보면 알 수 있듯이 실시예 2와 비교예 2에서 모두 여드름에 대해 그 효과가 있음을 알 수 있었다. 그러나 사용함에 있어 비교예 2의 경우는 실시예 2에 비해 자극이 비교적 심하여(임상 시험자의 약 10%) 장기적으로 사용하는 것이 부담스러운 반면, 실시예 2의 경우는 자극이 비교적 양호함과 동시에(임상 시험자의 약 4%)그 정도 또한 매우 경미하여 지속적인 사용이 가능하였다. 그리하여 실시예 2의 경우는 지속적인 사용에 따른 여드름 재발률이 거의 없었던 반면(1% 이내), 비교예 2의 경우는 사용 중지에 따른 여드름 재발 현상이 나타났다(약 20%). 따라서 자극여부 및 정도, 재발 가능성, 치유효과 등의 여러 가지 요소를 가지고 종합적으로 비교해 볼 때 실시예 2의 경우가 여드름 피부의 환자에게 더 적합하다는 것을 알 수 있었다.As can be seen from Table 4, in Example 2 and Comparative Example 2, it can be seen that the effect on the acne. However, in the case of the use of Comparative Example 2 compared to Example 2, the stimulation is relatively severe (about 10% of the clinical investigator), it is burdensome to use in the long term, while in Example 2, while the stimulation is relatively good ( About 4% of the clinical investigators were also very mild, allowing for continued use. Thus, in case of Example 2, acne recurrence rate was almost never (within 1%) due to continuous use, whereas in Comparative Example 2, acne recurrence phenomenon appeared due to discontinuation (about 20%). Therefore, when comparing comprehensively with various factors such as irritation and severity, the possibility of recurrence, healing effect, it can be seen that the case of Example 2 is more suitable for patients with acne skin.
상술한 바와 같이, 본 발명에 따른 여드름 피부에 효과를 가지는 화장료 조성물은 피부 모공 막힘의 방지와 여드름 원인 균주의 생장 억제를 동시에 가능케함으로써 피부에 자극을 주지 않으면서 장기적인 사용이 가능하며 이러한 지속적인 여드름 치료 및 관리는 여드름의 치료 뿐만 아니라 재발 가능성을 최소화시킨 매우 안전한 화장료 조성물을 제공할 수 있는 효과가 있다.As described above, the cosmetic composition having an effect on the acne skin according to the present invention enables the long-term use without irritating the skin by simultaneously preventing the clogging of the skin and inhibiting the growth of the acne-causing strains. And care has the effect of providing a very safe cosmetic composition that minimizes the likelihood of recurrence as well as the treatment of acne.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020018102A KR20030079231A (en) | 2002-04-02 | 2002-04-02 | Topical cosmetic products which have anti-acne efficacy for the patients with acne and their manufacturing methods. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020018102A KR20030079231A (en) | 2002-04-02 | 2002-04-02 | Topical cosmetic products which have anti-acne efficacy for the patients with acne and their manufacturing methods. |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030079231A true KR20030079231A (en) | 2003-10-10 |
Family
ID=32377602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020018102A KR20030079231A (en) | 2002-04-02 | 2002-04-02 | Topical cosmetic products which have anti-acne efficacy for the patients with acne and their manufacturing methods. |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20030079231A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200047430A (en) * | 2018-10-26 | 2020-05-07 | 주식회사 유나이티드엑티브 | Transepidermal delivery system comprising reverse micell |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03157311A (en) * | 1989-11-13 | 1991-07-05 | Kanebo Ltd | Cosmetic for common acne |
US5756471A (en) * | 1994-06-13 | 1998-05-26 | Institut Francais Du Petrole | Use of a sophorolipid to provide free radical formation inhibiting activity or elastase inhibiting activity |
KR19990077273A (en) * | 1996-11-15 | 1999-10-25 | 조지안느 플로 | Uses of octoxy glycerol used in cosmetic and / or dermatological compositions as active ingredients in the treatment of bruising and / or acne |
KR20000017297A (en) * | 1998-08-17 | 2000-03-25 | 조지안느 플로 | Cosmetic and/or dermatological composition containing salicylic acid or a salicylic acid derivative and its use |
JP2000109409A (en) * | 1998-10-05 | 2000-04-18 | Kao Corp | Acne prevention and amelioration agent |
KR20010044622A (en) * | 2001-03-12 | 2001-06-05 | 최승철 | Therapeutic composition for broad spectrum dermal disease |
WO2001070235A1 (en) * | 2000-03-20 | 2001-09-27 | Laboratoire D'evolution Dermatologique (L.E.D.) | Composition based on sphingolipid and beta-hydroxy-acid for skin care |
-
2002
- 2002-04-02 KR KR1020020018102A patent/KR20030079231A/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03157311A (en) * | 1989-11-13 | 1991-07-05 | Kanebo Ltd | Cosmetic for common acne |
US5756471A (en) * | 1994-06-13 | 1998-05-26 | Institut Francais Du Petrole | Use of a sophorolipid to provide free radical formation inhibiting activity or elastase inhibiting activity |
KR19990077273A (en) * | 1996-11-15 | 1999-10-25 | 조지안느 플로 | Uses of octoxy glycerol used in cosmetic and / or dermatological compositions as active ingredients in the treatment of bruising and / or acne |
KR20000017297A (en) * | 1998-08-17 | 2000-03-25 | 조지안느 플로 | Cosmetic and/or dermatological composition containing salicylic acid or a salicylic acid derivative and its use |
JP2000109409A (en) * | 1998-10-05 | 2000-04-18 | Kao Corp | Acne prevention and amelioration agent |
WO2001070235A1 (en) * | 2000-03-20 | 2001-09-27 | Laboratoire D'evolution Dermatologique (L.E.D.) | Composition based on sphingolipid and beta-hydroxy-acid for skin care |
KR20010044622A (en) * | 2001-03-12 | 2001-06-05 | 최승철 | Therapeutic composition for broad spectrum dermal disease |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200047430A (en) * | 2018-10-26 | 2020-05-07 | 주식회사 유나이티드엑티브 | Transepidermal delivery system comprising reverse micell |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2545691C2 (en) | Skin care compositions | |
DE2418386C2 (en) | Means for treating acne | |
Cohen et al. | Topical and surgical treatment of onychomycosis | |
KR20140060475A (en) | Compositions containing anti-acne agents and the use thereof | |
WO1999059580A1 (en) | Preventives/remedies for skin diseases | |
US8846646B2 (en) | Topical treatment of skin infection | |
KR20110036683A (en) | Benzoyl peroxide composition for treating skin | |
WO2018087766A1 (en) | Topical compositions for the treatment of acne | |
US20110236503A1 (en) | Topical Skincare Composition | |
DE60218227T2 (en) | TOPICAL DAPSONE FOR THE TREATMENT OF ACNE | |
JP2014501776A (en) | Melatonin and fungicides or antibacterial agents for the treatment of acne | |
EP1591125A1 (en) | Pharmaceutical composition comprising extracts of lichens and hypericum | |
EP0285856A2 (en) | Use of dihydroergotamine and its salts in the local treatment of trophic disorders | |
KR100593707B1 (en) | Cosmetic Products and their manufacturing methods helping to improve acnegenic and seborrheic skin through anti-microbial action and inhibitory action of sebum secretion. | |
EP2854748B1 (en) | Pharmaceutical composition for the treatment of skin inflammation and related syndromes | |
DE60212842T2 (en) | DERMATOLOGICAL COMPOSITIONS CONTAINING NICOTIC ACID OR NICOTIC ACID AMID AND SPHINGOID BASE | |
KR20030079231A (en) | Topical cosmetic products which have anti-acne efficacy for the patients with acne and their manufacturing methods. | |
EP1663195B1 (en) | Taurine bromamine for inhibiting pathogenic bacteria and fungi growth as well as in a microbicidal composition | |
EP1096947B1 (en) | Topical drug for the treatment of viral infections | |
EP2620146A1 (en) | Ibuprofen for treating actinic keratosis | |
Faergemann et al. | Scalp psoriasis: synergy between the Malassezia yeasts and skin irritation due to calcipotriol | |
WO2019175902A1 (en) | A topical preparation for various skin ailments | |
US10071052B2 (en) | Method for the prevention and treatment of acne | |
WO1983000628A1 (en) | A method of treating acne vulgaris and composition containing carbamide peroxide | |
US20150118292A1 (en) | Compositions and methods for treatment of hair loss |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |